Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelia Brunner

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|December 6, 2023
Corrigendum: Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinomaJiantong Bao, Annika C Betzler, Jochen Hess, et al.
Journal of Clinical Immunology|August 1, 2002
Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemiaCornelia Brunner, Hans Wolfgang Kreth, Hans D Ochs, et al.
Radiology Case Reports|March 29, 2022
Flow dynamics in acute ischemic stroke due to embolic occlusion of a fetal posterior cerebral artery treated with endovascular thrombectomy - report of two casesKarl Matz, Andrei Apetroe, Andreas Chemelli, et al.
Eneurologicalsci|November 17, 2022
MOG antibody associated disease (MOGAD) presenting with extensive brain stem encephalitis: A case reportElisabeth Olbert, Cornelia Brunner, Naela Alhani, et al.
Immunobiology|November 20, 2002
Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytesCornelia Brunner, Andris Avots, Hans Wolfgang Kreth, et al.
The Journal of Biological Chemistry|August 30, 2003
Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytesCornelia Brunner, Helmut Laumen, Peter J Nielsen, et al.
The Journal of Experimental Medicine|May 7, 2003
B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient miceCornelia Brunner, Dragan Marinkovic, Jörg Klein, et al.
Immunotherapy|April 5, 2019
Immunotherapy for head and neck cancers: an update and future perspectivesJohannes Doescher, Simon Laban, Patrick J Schuler, et al.
European Journal of Immunology|September 13, 2015
NF-κB-dependent signals control BOB.1/OBF.1 and Oct2 transcriptional activity in B cellsMelanie Kilzheimer, Jasmin Quandt, Julia Langhans, et al.
The Journal of Biological Chemistry|January 5, 2011
The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activationLysann Palkowitsch, Uta Marienfeld, Cornelia Brunner, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|December 6, 2023
Corrigendum: Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinomaJiantong Bao, Annika C Betzler, Jochen Hess, et al.
Journal of Clinical Immunology|August 1, 2002
Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemiaCornelia Brunner, Hans Wolfgang Kreth, Hans D Ochs, et al.
Radiology Case Reports|March 29, 2022
Flow dynamics in acute ischemic stroke due to embolic occlusion of a fetal posterior cerebral artery treated with endovascular thrombectomy - report of two casesKarl Matz, Andrei Apetroe, Andreas Chemelli, et al.
Eneurologicalsci|November 17, 2022
MOG antibody associated disease (MOGAD) presenting with extensive brain stem encephalitis: A case reportElisabeth Olbert, Cornelia Brunner, Naela Alhani, et al.
Immunobiology|November 20, 2002
Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytesCornelia Brunner, Andris Avots, Hans Wolfgang Kreth, et al.
The Journal of Biological Chemistry|August 30, 2003
Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytesCornelia Brunner, Helmut Laumen, Peter J Nielsen, et al.
The Journal of Experimental Medicine|May 7, 2003
B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient miceCornelia Brunner, Dragan Marinkovic, Jörg Klein, et al.
Immunotherapy|April 5, 2019
Immunotherapy for head and neck cancers: an update and future perspectivesJohannes Doescher, Simon Laban, Patrick J Schuler, et al.
European Journal of Immunology|September 13, 2015
NF-κB-dependent signals control BOB.1/OBF.1 and Oct2 transcriptional activity in B cellsMelanie Kilzheimer, Jasmin Quandt, Julia Langhans, et al.
The Journal of Biological Chemistry|January 5, 2011
The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activationLysann Palkowitsch, Uta Marienfeld, Cornelia Brunner, et al.
Pageof 11